NEONATAL PLUS VITAMIN- neonatal plus vitamin tablet 
NEOMED PHARMACEUTICAL

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

NEONATAL PLUS VITAMIN
prenatal/postnatal multi-vitamin/mineral tablet
Rx 

WARNING

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

Each prenatal tablet contains:

Each Tablet contains:

Vitamin A (as acetate, beta carotene)

1200 mcg

Vitamin D3 (as cholecalciferol)

10 mcg

Vitamin E (as dl-alpha topcopheryl acetate )

9.2 mg

Vitamin C (Ascorbic acid )

20 mg 

Vitamin B1 (as thiamine HCl)

1.84 mg

Vitamin B2 (as riboflavin)

3 mg

Vitamin B3 (as niacinamide)

20 mg

Vitamin B6 (as pyridoxine HCl)

10 mg

Folic acid

1000 mcg

Vitamin B12 (as cyanocobalamin)

12 mcg

Iron  (as ferrous fumarate )

27 mg

Citrus bioflavonoids complex 50% bio flavonoids

2 mg

Calcium (as carbonate sulfate )

200 mg

Zinc (as zinc oxide )

25 mg

Copper (as cupric oxide)

2 mg

Boron (as boron citrate )

0.2 mg

Inositol

5 mg

Other Ingredients: , microcrystalline  croscarmellose sodium, stearic acid, silicon dioxide, titanium dioxide (as color), polyethylene glycol, sucrose, magnesium stearate, talc,triacetin, HPMC E15,HPMC E5/E6,FD&C RED #40 (LAKES),FD&C YELLOW # 6 (LAKE )

NEONATAL PLUS TABLET  Rx is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

PRECAUTIONS

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

To report a serious adverse event or obtain product information, call 631-524-5758

DOSAGE AND ADMINISTRATION

One tablet daily or as directed by a physician.

HOW SUPPLIED

Bottles of 100 tablets each - NDC 70898-115-01

STORAGE

Store at 20-25°C (68-77°F) [See USP controlled room temperature].

To report a serious adverse event or obtain product information, call 631-524-5758

Distributed by:

Neomed Pharmaceutical ,80 Cain Dr, Brentwood,NY 11717

Phone :631-524-5758

Email: info@neomedpharmaceutical.com

100 Count

NEONATAL PLUS VITAMIN 
neonatal plus vitamin tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70898-115
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
VITAMIN A (UNII: 81G40H8B0T) (VITAMIN A - UNII:81G40H8B0T) VITAMIN A1200 ug
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID20 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL10 ug
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) (.ALPHA.-TOCOPHEROL - UNII:H4N855PNZ1) .ALPHA.-TOCOPHEROL ACETATE9.2 mg
THIAMINE (UNII: X66NSO3N35) (THIAMINE ION - UNII:4ABT0J945J) THIAMINE1.84 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN3 mg
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE20 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE10 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1000 ug
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN12 ug
FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION27 mg
INOSITOL (UNII: 4L6452S749) (INOSITOL - UNII:4L6452S749) INOSITOL5 mg
CITRUS BIOFLAVONOIDS (UNII: BD70459I50) (HESPERIDIN - UNII:E750O06Y6O) CITRUS BIOFLAVONOIDS2 mg
CALCIUM (UNII: SY7Q814VUP) (CALCIUM - UNII:SY7Q814VUP) CALCIUM200 mg
BORON (UNII: N9E3X5056Q) (BORON - UNII:N9E3X5056Q) BORON0.2 mg
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION25 mg
COPPER (UNII: 789U1901C5) (COPPER - UNII:789U1901C5) COPPER2 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
TALC (UNII: 7SEV7J4R1U)  
POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
TRIACETIN (UNII: XHX3C3X673)  
SUCROSE (UNII: C151H8M554)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
Product Characteristics
Colorbrown (BEIGE/PEACH) Scoreno score
ShapeCAPSULE (Caplet) Size5mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70898-115-011 in 1 PACKAGE07/31/2018
1100 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/31/2018
Labeler - NEOMED PHARMACEUTICAL (048388130)

Revised: 9/2020
Document Id: 65f35737-6135-4e75-a0be-02260522d5ef
Set id: d6f0af28-1e4a-4b06-9ff5-fc15f3f13ea9
Version: 4
Effective Time: 20200918
 
NEOMED PHARMACEUTICAL